Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
Julien Favresse, Constant Gillot, Laura Di Chiaro, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1092-1092
Open Access | Times Cited: 113
Adaptive Immune Responses and Immunity to SARS-CoV-2
Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 90
Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers
Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 48
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers
Evangelos Terpos, Ioannis P. Trougakos, Vangelis Karalis, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1942-1942
Open Access | Times Cited: 43
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis
Luojia Deng, Peiqi Li, Xuezhixing Zhang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
Constant Gillot, Julien Favresse, Clara David, et al.
Microbiology Research (2024) Vol. 15, Iss. 1, pp. 422-430
Open Access | Times Cited: 5
Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection
Yuqi Zhang, Xinjie Li, Yingxiang Yang, et al.
Vaccine (2025) Vol. 48, pp. 126722-126722
Closed Access
Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers
Irmak Güzel, Gamze ÖZTÜRK, Özgür Appak, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples
Kwok‐Hung Chan, Ka‐Yi Leung, Ruiqi Zhang, et al.
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1757-1757
Open Access | Times Cited: 38
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study
Troy J. Kemp, Heidi Hempel, Yuanji Pan, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 12
Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
Jonathan Douxfils, Constant Gillot, François Mullier, et al.
Journal of Infection (2021) Vol. 83, Iss. 4, pp. e4-e5
Open Access | Times Cited: 28
Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
Miku Nakai, Daisuke Yokoyama, Tomoaki Sato, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16547-e16547
Open Access | Times Cited: 10
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
Kahina Saker, Bruno Pozzetto, Vanessa Escuret, et al.
Journal of Clinical Virology (2022) Vol. 152, pp. 105169-105169
Open Access | Times Cited: 17
Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
Zhangkai J. Cheng, Bizhou Li, Zhiqing Zhan, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 64, Iss. 1, pp. 17-32
Open Access | Times Cited: 16
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
Giacomo Malipiero, Pierlanfranco D’Agaro, Ludovica Segat, et al.
Clinica Chimica Acta (2021) Vol. 524, pp. 11-17
Open Access | Times Cited: 22
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2
Gabriel Siracusano, Alessandra Ruggiero, Zeno Bisoffi, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review
Eliete Neves Silva Guerra, Vitória Tavares de Castro, Juliana Amorim dos Santos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein
Yu‐Lei Chen, Jin-Jin Lin, Huan Ma, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10904-10904
Open Access | Times Cited: 12
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
Qiqi Ma, Xiang Li, Gaosi Xu
Viruses (2022) Vol. 14, Iss. 10, pp. 2143-2143
Open Access | Times Cited: 12
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Andrea Carolina Machado-Sulbarán, et al.
Immunology Letters (2022) Vol. 251-252, pp. 20-28
Open Access | Times Cited: 12
Sex‐specific disparities in COVID‐19 outcomes
Zubaid Rafique, Valerie Durkalski‐Mauldin, W. Frank Peacock, et al.
Journal of the American College of Emergency Physicians Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing
Constant Gillot, Jean‐Louis Bayart, Mélanie Closset, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 9, pp. 1670-1675
Open Access | Times Cited: 6
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
Constant Gillot, Julien Favresse, Vincent Maloteau, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2329-2329
Open Access | Times Cited: 15
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
Chin-Shern Lau, Soon Kieng Phua, Ya-Li Liang, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1241-1241
Open Access | Times Cited: 14
Proteomics Investigation of Diverse Serological Patterns in COVID-19
Xiao Liang, Rui Sun, Jing Wang, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 2, pp. 100493-100493
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top